Article
Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia
13 Mar 2020
Abstract excerpt
BACKGROUND: The interest in plasma biomarkers has increased recently. Plasma exosome-derived microRNA-532 is aberrantly expressed in a variety of human cancers and has the prognostic value in many solid tumors. However, the prognostic impact of the expression value on AML remains unclear. OBJECTIVE: The aim of this study is to investigate the prognostic value of exosome-derived microRNA-532 in AML patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
